Stockreport

TherapeuticsMD Provides COVID-19-Related Business Update

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com
PDF - Strong preliminary first quarter 2020 total net revenue projected to be more than $11 million –- vitaCare Prescription Services model allowing the Company to connect w [Read more]